ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $8,157,000 | +325.1% | 65,000 | +333.3% | 0.94% | +354.3% |
Q4 2020 | $1,919,000 | -93.0% | 15,000 | -93.9% | 0.21% | -93.3% |
Q3 2020 | $27,485,000 | +12.1% | 244,249 | -5.1% | 3.09% | +38.4% |
Q2 2020 | $24,508,000 | +27.1% | 257,249 | +19.9% | 2.23% | -36.8% |
Q1 2020 | $19,281,000 | – | 214,538 | – | 3.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |